162 related articles for article (PubMed ID: 19852026)
1. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy.
Milone M; Katz A; Amato AA; Soderland CA; Segarceanu M; Young NP; Jones HR
Muscle Nerve; 2010 Feb; 41(2):272-6. PubMed ID: 19852026
[TBL] [Abstract][Full Text] [Related]
2. Sporadic late onset nemaline myopathy.
Chahin N; Selcen D; Engel AG
Neurology; 2005 Oct; 65(8):1158-64. PubMed ID: 16148261
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Novy J; Rosselet A; Spertini O; Lobrinus JA; Pabst T; Kuntzer T
Muscle Nerve; 2010 Feb; 41(2):286-7. PubMed ID: 19918772
[No Abstract] [Full Text] [Related]
4. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen.
Kumutpongpanich T; Owattanapanich W; Tanboon J; Nishino I; Boonyapisit K
Neuromuscul Disord; 2018 Jul; 28(7):610-613. PubMed ID: 29910095
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of sporadic late onset nemaline myopathy effectively treated with immunotherapy].
Mizuno Y; Mori-Yoshimura M; Okamoto T; Oya Y; Nishino I; Murata M
Rinsho Shinkeigaku; 2016 Sep; 56(9):605-11. PubMed ID: 27580764
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS.
de Sanctis JT; Cumbo-Nacheli G; Dobbie D; Baumgartner D
AIDS Read; 2008 Feb; 18(2):90-4. PubMed ID: 18330038
[TBL] [Abstract][Full Text] [Related]
7. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease.
Doppler K; Knop S; Einsele H; Sommer C; Wessig C
Muscle Nerve; 2013 Dec; 48(6):983-8. PubMed ID: 23873431
[TBL] [Abstract][Full Text] [Related]
8. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: Report of four patients.
Okhovat AA; Nilipour Y; Boostani R; Vahabizad F; Najmi S; Nafissi S; Fatehi F
Neuromuscul Disord; 2021 Jan; 31(1):29-34. PubMed ID: 33308940
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
Kotchetkov R; Susman D; Bhutani D; Broch K; Dispenzieri A; Buadi FK
Int J Cancer; 2021 Jun; 148(11):2807-2814. PubMed ID: 33529362
[TBL] [Abstract][Full Text] [Related]
10. Sporadic Late-Onset Nemaline Myopathy: Current Landscape.
Nicolau S; Milone M
Curr Neurol Neurosci Rep; 2023 Nov; 23(11):777-784. PubMed ID: 37856049
[TBL] [Abstract][Full Text] [Related]
11. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.
Monforte M; Primiano G; Silvestri G; Mirabella M; Luigetti M; Cuccagna C; Ricci E; Servidei S; Tasca G
J Neurol; 2018 Mar; 265(3):542-551. PubMed ID: 29356967
[TBL] [Abstract][Full Text] [Related]
12. Sporadic late-onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset.
Maeda MH; Ohta H; Izutsu K; Shimizu J; Uesaka Y
Muscle Nerve; 2015 May; 51(5):772-4. PubMed ID: 25381859
[TBL] [Abstract][Full Text] [Related]
13. Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment.
Nandy A; Tankisi H; Krøigård AB; Dalager MG; Hvidbjerg MS; Schrøder HD; Obál I
BMC Neurol; 2023 Jun; 23(1):233. PubMed ID: 37328820
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.
Tanboon J; Uruha A; Arahata Y; Dittmayer C; Schweizer L; Goebel HH; Nishino I; Stenzel W
Brain Pathol; 2021 May; 31(3):e12962. PubMed ID: 34043258
[TBL] [Abstract][Full Text] [Related]
15. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.
Schnitzler LJ; Schreckenbach T; Nadaj-Pakleza A; Stenzel W; Rushing EJ; Van Damme P; Ferbert A; Petri S; Hartmann C; Bornemann A; Meisel A; Petersen JA; Tousseyn T; Thal DR; Reimann J; De Jonghe P; Martin JJ; Van den Bergh PY; Schulz JB; Weis J; Claeys KG
Orphanet J Rare Dis; 2017 May; 12(1):86. PubMed ID: 28490364
[TBL] [Abstract][Full Text] [Related]
16. Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes.
Naddaf E; Milone M; Kansagra A; Buadi F; Kourelis T
Neurology; 2019 Jul; 93(3):e298-e305. PubMed ID: 31167932
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti-α-Actinin Immunostaining.
Zhao B; Dai T; Zhao D; Ma X; Zhao C; Li L; Sun Y; Zhang Y; Yan Y; Lu JQ; Liu F; Yan C
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35581006
[TBL] [Abstract][Full Text] [Related]
18. [Treatability of sporadic late onset nemaline myopathy].
Hanisch F; Schneider I; Müller T; Romeike BF; Stoltenburg G; Holzhausen HJ; Zierz S
Nervenarzt; 2013 Aug; 84(8):955-61. PubMed ID: 23836301
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy.
Wang M; Lei L; Chen H; Di L; Pang M; Lu Y; Lu L; Shen XM; Da Y
Neuromuscul Disord; 2017 Oct; 27(10):942-946. PubMed ID: 28606401
[TBL] [Abstract][Full Text] [Related]
20. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
